About the project
A global pharmaceutical government affairs team sought to strengthen its support for Chinese affiliates. The first step was to improve planning by grounding global business priorities in China’s evolving national and provincial policy landscape.
Working with in country partners, Hinton Advisers reviewed the latest developments, including the 14th Five Year Plan, the 2026 Two Sessions, and wider national policy signals, alongside deep dives across priority provinces to identify local opportunities and risks.
Challenge
Global team was committed to expanding their government affairs footprint in China but faced fragmented communication, inconsistent policy priorities, and limited visibility into local stakeholder expectations. They needed a structured, intelligence‑driven approach that connected global strategy with China’s political realities and enabled more coordinated, proactive engagement.
Our strategic approach
National and provincial landscape analysis
Mapped policy trends and conducted interviews across key provinces to surface local insights.
Portfolio aligned policy mapping
Identified where national and provincial priorities aligned with the company’s products and future launches.
Planning tools and capability building
Developed processes and templates for Chinese colleagues to create their own plans, refining them collaboratively to ensure alignment and local relevance.
A tailored solution
We worked with global and in country teams to produce aligned, portfolio relevant government affairs plans supported by a repeatable planning framework. This now enables more coordinated, insight driven government affairs engagement and strengthens the organisation’s ability to deliver on its business and policy objectives in China.